![Denosumab biosimilar in postmenopausal osteoporotic women: A randomized, assessor-blind, active-controlled clinical trial Denosumab biosimilar in postmenopausal osteoporotic women: A randomized, assessor-blind, active-controlled clinical trial](https://ijp-online.com/articles/2021/53/1/images/Indian%20J%20Pharmacol_2021_53_1_6_315079_f1.jpg)
Denosumab biosimilar in postmenopausal osteoporotic women: A randomized, assessor-blind, active-controlled clinical trial
Efficacy and Safety of the RTS,S/AS01 Malaria Vaccine during 18 Months after Vaccination: A Phase 3 Randomized, Controlled Trial in Children and Young Infants at 11 African Sites | PLOS Medicine
![Intention-to-treat analysis may be more conservative than per protocol analysis in antibiotic non-inferiority trials: a systematic review | BMC Medical Research Methodology | Full Text Intention-to-treat analysis may be more conservative than per protocol analysis in antibiotic non-inferiority trials: a systematic review | BMC Medical Research Methodology | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs12874-021-01260-7/MediaObjects/12874_2021_1260_Fig3_HTML.png)
Intention-to-treat analysis may be more conservative than per protocol analysis in antibiotic non-inferiority trials: a systematic review | BMC Medical Research Methodology | Full Text
![New regimens of benznidazole monotherapy and in combination with fosravuconazole for treatment of Chagas disease (BENDITA): a phase 2, double-blind, randomised trial - The Lancet Infectious Diseases New regimens of benznidazole monotherapy and in combination with fosravuconazole for treatment of Chagas disease (BENDITA): a phase 2, double-blind, randomised trial - The Lancet Infectious Diseases](https://www.thelancet.com/cms/attachment/4b808ecb-fac4-4fda-bb1a-7cd275cbc3db/gr1_lrg.jpg)
New regimens of benznidazole monotherapy and in combination with fosravuconazole for treatment of Chagas disease (BENDITA): a phase 2, double-blind, randomised trial - The Lancet Infectious Diseases
![Screening: the information individuals need to support their decision: per protocol analysis is better than intention-to-treat analysis at quantifying potential benefits and harms of screening | BMC Medical Ethics | Full Text Screening: the information individuals need to support their decision: per protocol analysis is better than intention-to-treat analysis at quantifying potential benefits and harms of screening | BMC Medical Ethics | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2F1472-6939-15-28/MediaObjects/12910_2014_Article_268_Fig1_HTML.jpg)
Screening: the information individuals need to support their decision: per protocol analysis is better than intention-to-treat analysis at quantifying potential benefits and harms of screening | BMC Medical Ethics | Full Text
![FOLFIRI plus cetuximab or bevacizumab for advanced colorectal cancer: final survival and per-protocol analysis of FIRE-3, a randomised clinical trial | British Journal of Cancer FOLFIRI plus cetuximab or bevacizumab for advanced colorectal cancer: final survival and per-protocol analysis of FIRE-3, a randomised clinical trial | British Journal of Cancer](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41416-020-01140-9/MediaObjects/41416_2020_1140_Fig2_HTML.png)
FOLFIRI plus cetuximab or bevacizumab for advanced colorectal cancer: final survival and per-protocol analysis of FIRE-3, a randomised clinical trial | British Journal of Cancer
![Signifience - Intention-to-Treat (ITT) vs. Per Protocol (PP) : How to choose the right clinical trial population Signifience - Intention-to-Treat (ITT) vs. Per Protocol (PP) : How to choose the right clinical trial population](https://www.signifience.com/wp-content/uploads/2022/10/Groupe_people_01_01S-scaled-e1672600105362.jpg)
Signifience - Intention-to-Treat (ITT) vs. Per Protocol (PP) : How to choose the right clinical trial population
![Diagram illustrating the study population in the per-protocol study... | Download Scientific Diagram Diagram illustrating the study population in the per-protocol study... | Download Scientific Diagram](https://www.researchgate.net/publication/346490800/figure/fig1/AS:963553221689363@1606740398360/Diagram-illustrating-the-study-population-in-the-per-protocol-study-design-Orange.png)
Diagram illustrating the study population in the per-protocol study... | Download Scientific Diagram
![Trial profile. Population: ITT = intention-to-treat, PP = per protocol. | Download Scientific Diagram Trial profile. Population: ITT = intention-to-treat, PP = per protocol. | Download Scientific Diagram](https://www.researchgate.net/publication/322154218/figure/fig2/AS:991448019243010@1613391036225/Trial-profile-Population-ITT-intention-to-treat-PP-per-protocol.png)